切换至 "中华医学电子期刊资源库"

中华口腔医学研究杂志(电子版) ›› 2016, Vol. 10 ›› Issue (05) : 322 -326. doi: 10.3877/cma.j.issn.1674-1366.2016.05.004

所属专题: 文献

基础研究

CD133在口腔扁平苔藓和口腔鳞状细胞癌中的表达及其临床意义
孙艳1, 祁佳佳1, 袁昌青2,(), 徐全臣2, 赵涵2, 曹远盼1, 刘秋艳1   
  1. 1. 266000 青岛大学口腔医学院
    2. 266000 青岛大学附属医院口腔科
  • 收稿日期:2016-08-02 出版日期:2016-10-01
  • 通信作者: 袁昌青
  • 基金资助:
    山东省研究生教育创新计划(SDYY11184)

The clinical significance of the expression of CD133 in oral lichen planus and oral squamous cell carcinoma

Yan Sun1, Jiajia Qi1, Changqing Yuan2,(), Quanchen Xu2, Han Zhao2, Yuanpan Cao1, Qiuyan Liu1   

  1. 1. School of Stomatology, Qingdao University, Qingdao 266000, China
    2. Department of Stomatology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China
  • Received:2016-08-02 Published:2016-10-01
  • Corresponding author: Changqing Yuan
  • About author:
    Corresponding author: Yuan Changqing, Email:
引用本文:

孙艳, 祁佳佳, 袁昌青, 徐全臣, 赵涵, 曹远盼, 刘秋艳. CD133在口腔扁平苔藓和口腔鳞状细胞癌中的表达及其临床意义[J]. 中华口腔医学研究杂志(电子版), 2016, 10(05): 322-326.

Yan Sun, Jiajia Qi, Changqing Yuan, Quanchen Xu, Han Zhao, Yuanpan Cao, Qiuyan Liu. The clinical significance of the expression of CD133 in oral lichen planus and oral squamous cell carcinoma[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2016, 10(05): 322-326.

目的

探究肿瘤干细胞标记物CD133在口腔正常黏膜、口腔扁平苔藓(OLP)及口腔鳞状细胞癌(OSCC)中的表达情况及临床意义,评估其作为OLP恶性转化的早期诊断指标、OSCC治疗干预靶标的临床价值,为进一步研究口腔黏膜癌变机制提供基础。

方法

回顾性分析10例正常口腔黏膜、60例OLP、60例OSCC患者的临床资料,运用免疫组织化学技术检测各组病理组织中CD133表达情况,采用Mann-Whiney秩和检验比较各组间CD133表达差异,卡方检验统计分析CD133与各临床因素的关系。采用免疫组织化学技术和免疫印迹技术检测人口腔癌前病变细胞株(DOK)和人OSCC细胞株(CAL-27)中CD133的表达情况,t检验比较CD133在DOK与CAL-27细胞株中含量差异。

结果

口腔正常黏膜、OLP、OSCC三组中,CD133的阳性率为0(0/10)、31.67%(19/60)、63.33%(38/60),表达逐渐增强。CD133在口腔正常黏膜与OLP表达强度差异有统计学意义(Z=-2.046,P= 0.041)。CD133在OLP与OSCC表达强度差异具有统计学意义(Z=-3.777,P<0.001)。CD133在DOK中弱阳性表达,在CAL-27中阳性表达,DOK与CAL-27中CD133含量差异有统计学意义(t=-5.029,P= 0.001)CD133与OSCC的临床分期和淋巴结转移有关。

结论

CD133作为评估OLP恶性转化潜能的指标及OSCC早期治疗干预靶标可能具有重要临床价值。

Objective

To investigate the expression of CD133 in oral normal mucosa, oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC) , to analyze the relationship between its expression and the clinical factors, and to evaluate the significnce of CD133 as an index to evaluate the canceration potency of OLP.

Methods

Immunohistochemical analysis and Mann-Whiney test were applied to investigate the expression of CD133 in paraffin section of human oral normal mucosa, OLP and OSCC tissues. Then the relationships between its expression and clinical factors were analyzed. Immunohistochemical analysis, Western blot analysis and t test were also applied to investigate the expression of CD133 in human dysplastic oral keratinocyte (DOK) cell line and human oral squamous cell carcinoma (CAL-27) cell line.

Results

A gradual increase in the expression of CD133 was observed in three groups, the positive rates of CD133 were 0 (0/10) , 31.67% (19/60) , 63.33% (38/60) respectively. Significant differences were observed in expression of CD133 in oral normal mucosa and OLP (Z=-2.046, P= 0.041) , OLP and OSCC (Z=-3.777, P<0.001) . An increase in the expression of CD133 were also observed from DOK cell line to CAL-27 cell line (t=-5.029, P= 0.001) .

Conclusion

CD133 can be used as clinical index to evaluate the canceration potency of oral lichen planus.

表1 正常口腔黏膜、OLP及OSCC组织中CD133表达强度的比较(例)
图1 正常口腔黏膜、OLP及OSCC组织中CD133的表达(IHC × 200)
表2 CD133表达与临床因素的关系
图2 DOK及CAL-27细胞株中CD133的表达(IHC × 200)
图3 DOK及CAL-27细胞株中CD133的含量
[1]
Ravindran G, Devaraj H. Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors[J]. Head Neck,2012,34(8):1129-1135.
[2]
Abdulmajeed AA, Dalley AJ, Farah CS. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma[J]. J Oral Pathol Med,2013,42(10):755-760.
[3]
陈谦明.口腔黏膜病学[M]. 3版.北京:人民卫生出版社,2008:109-113.
[4]
Yardimci G, Kutlubay Z, Engin B,et al. Precancerous lesions of oral mucosa[J]. World J Clin Cases,2014,2(12):866-872.
[5]
Sun L, Feng J, Ma L,et al. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma[J]. Ann Diagn Pathol,2013,17(6):486-489.
[6]
Felthaus O, Ettl T, Gosau M,et al. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines[J]. Biochem Biophys Res Commun,2011,407(1):28-33.
[7]
Sun Y, Han J, Lu Y,et al. Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma[J]. Oral Dis,2012,18(2):169-177.
[8]
Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia:a systematic review of observational studies[J]. J Oral Pathol Med,2016,45(3):155-166.
[9]
Liu W, Wu L, Shen XM,et al. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia[J]. Int J Cancer,2013,132(4):868-874.
[10]
Hsu HS, Huang PI, Chang YL,et al. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells[J]. Cancer,2011,117(13):2970-2985.
[11]
Zhang Q, Shi S, Yen Y,et al. A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy[J]. Cancer Lett,2010,289(2):151-160.
[12]
Damek-Poprawa M, Volgina A, Korostoff J,et al. Targeted inhibition of CD133+ cells in oral cancer cell lines[J]. J Dent Res,2011,90(5):638-645.
[13]
农晓琳,徐铭竹,李昊,等. CXCR4 CD44 CD133表达在舌鳞状细胞癌患者生存分析中的价值[J].中国肿瘤临床,2013,40(14):832-837.
[14]
陈万涛.口腔颌面-头颈部肿瘤生物学[M].上海:上海交通大学出版社,2015:53-57.
[15]
唐毕锋,马立业.肿瘤干细胞及其与CDl33的关系[J].国际肿瘤学杂志,2008,35(5):326-329.
[16]
Barcelos LS, Duplaa C, Kränkel N,et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling[J]. Circ Res,2009,104(9):1095-1102.
[17]
Yi XJ, Zhao YH, Qiao LX,et al. Abrrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorrigenicity[J]. Mol Med Rep,2015,12(4):5042-5048.
[18]
de Sousa E Melo F, Vermeulen L. Wnt signaling in cancer stem cell biology[J]. Cancers,2016,8(7):E60.
[1] 张文涵, 王成. 瘢痕鳞状细胞癌的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(01): 59-64.
[2] 李晨曦, 谭小容, 魏巍, 李慕秋, 龚忠诚. 三级淋巴结构在口腔癌中的特征及意义[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 315-321.
[3] 胡伟涛, 李星瀚, 刘琦, 孟贺, 马琳, 邓永强. 微小核糖核酸-21在口腔鳞状细胞癌中作为生物学标志物的研究进展[J]. 中华口腔医学研究杂志(电子版), 2022, 16(05): 328-332.
[4] 肖倩, 张丹丹, 张婷, 贺婵娟, 张伟芳, 吴登旬, 刘英. 树突状细胞在口腔扁平苔藓发病机制中的作用[J]. 中华口腔医学研究杂志(电子版), 2022, 16(04): 229-233.
[5] 杨引申, 刘洋, 许晓珩, 姜啸, 孟文霞. 口腔扁平苔藓与系统性疾病关系的研究进展[J]. 中华口腔医学研究杂志(电子版), 2022, 16(04): 224-228.
[6] 邓昊, 苏葵, 贾丽华, 吕倩书, 欧阳樱紫. Er:YAG激光联合他克莫司软膏治疗口腔扁平苔藓的临床研究[J]. 中华口腔医学研究杂志(电子版), 2022, 16(04): 219-223.
[7] 左雯鑫, 袁理, 杨天慧, 汤剑明, 周芷伊, 何飞. 长链非编码RNA基因芯片技术筛选口腔扁平苔藓唾液外泌体差异表达基因[J]. 中华口腔医学研究杂志(电子版), 2022, 16(04): 208-218.
[8] 陈晰娟, 夏娟. 口腔扁平苔藓的治疗进展[J]. 中华口腔医学研究杂志(电子版), 2022, 16(04): 203-207.
[9] 吕宗凯, 郑杨灿, 杜胜男, 杨映阳. Nd:YAG激光治疗口腔扁平苔藓疗效的Meta分析[J]. 中华口腔医学研究杂志(电子版), 2022, 16(02): 100-105.
[10] 马慧颖, 何志良, 李士辉, 岳琳, 李春佳. 铒激光联合曲安奈德治疗口腔黏膜下纤维化的疗效评价[J]. 中华口腔医学研究杂志(电子版), 2021, 15(06): 355-359.
[11] 李众, 姚小武, 陈仕生, 卢子正, 林敏校, 桂心伟. Toll样受体9和环氧合酶2在口腔鳞状细胞癌及癌旁组织中的表达意义[J]. 中华口腔医学研究杂志(电子版), 2021, 15(06): 333-340.
[12] 王芳, 刘炀, 周明莉, 高琪. 精神心理因素与口腔扁平苔藓的相关性研究进展[J]. 中华口腔医学研究杂志(电子版), 2021, 15(05): 320-324.
[13] 罗小波, 但红霞, 陈谦明. 线上教学在口腔黏膜病学授课中的应用探讨[J]. 中华口腔医学研究杂志(电子版), 2021, 15(02): 110-113.
[14] 朱伟芳, 方红. 联合窄波紫外线治疗皮肤扁平苔藓样慢性移植物抗宿主病一例[J]. 中华移植杂志(电子版), 2021, 15(03): 169-171.
[15] 王博, 郭利君, 李二强, 张贺林, 徐鹏, 杨晓春. 消化道与口腔黏膜组织在输尿管重建中的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 434-439.
阅读次数
全文


摘要